首页 > 最新文献

Trends in Psychiatry and Psychotherapy最新文献

英文 中文
From Hippocrates to the Ages of Technology: A Narrative Review of the Evolution of the doctor-patient Relationship. 从希波克拉底到技术时代:医患关系演变的叙事回顾。
IF 2.1 Q3 PSYCHIATRY Pub Date : 2025-01-02 DOI: 10.47626/2237-6089-2024-0934
Isabela Azeredo Melca, Rachel Moraes Ferreira, Antonio Egídio Nardi, Anna Lucia Spear King

Objectives: Thus, through a narrative review, this article analyzes how the advancement of technology, the use of digital resources, and social media have impacted the doctor-patient relationship.

Methods: We conducted a scoping review on the relationship between Digital Health Equity and Telemedicine and e-health via Scopus and Pubmed electronic databases. The following inclusion criteria were established: papers on the relationship between digital health equity and telemedicine and e-health, written in English and with no time limits. All study designs were eligible, including those that have utilized qualitative and quantitative methods, methodology, or guidelines reports, except for meta-reviews.

Results: With the advancement of technology and social media, a change in behavior in the population and the doctor-patient relationship was observed. Through the help of digital devices, the increased prevalence of social networks, and asynchronous consultations new opportunities were created to bring doctors and patients closer. The relationship has shifted from face-to-face and paternalistic to virtual communication with shared decisions in recent decades. It was observed that the advancement of technology and the use of digital resources have reshaped the roles of doctors and patients and their relationships.

Conclusion: Technology is the leading cause for an informed, more involved, and responsible patient. However, physicians have conflicting opinions about the use of these technologies. While recognizing its benefits for patients, they are also concerned about digital health and its impact.

目的:因此,通过叙述回顾,本文分析了技术的进步、数字资源的使用和社交媒体是如何影响医患关系的。方法:我们通过Scopus和Pubmed电子数据库对数字健康公平与远程医疗和电子卫生之间的关系进行了范围审查。确定了以下纳入标准:关于数字保健公平与远程医疗和电子保健之间关系的论文,用英文撰写,没有时间限制。所有的研究设计都是合格的,包括那些使用了定性和定量方法、方法学或指南报告的研究,除了meta综述。结果:随着科技和社交媒体的进步,人群的行为和医患关系发生了变化。在数字设备的帮助下,社交网络的日益普及和异步咨询创造了新的机会,使医生和病人更接近。近几十年来,这种关系已经从面对面和家长式的关系转变为共同决策的虚拟交流。会议指出,技术进步和数字资源的使用重塑了医患角色及其关系。结论:技术是导致患者见多识广、更积极参与、更负责任的主要原因。然而,医生们对这些技术的使用有不同的看法。在认识到数字医疗对患者的好处的同时,他们也对数字医疗及其影响感到担忧。
{"title":"From Hippocrates to the Ages of Technology: A Narrative Review of the Evolution of the doctor-patient Relationship.","authors":"Isabela Azeredo Melca, Rachel Moraes Ferreira, Antonio Egídio Nardi, Anna Lucia Spear King","doi":"10.47626/2237-6089-2024-0934","DOIUrl":"https://doi.org/10.47626/2237-6089-2024-0934","url":null,"abstract":"<p><strong>Objectives: </strong>Thus, through a narrative review, this article analyzes how the advancement of technology, the use of digital resources, and social media have impacted the doctor-patient relationship.</p><p><strong>Methods: </strong>We conducted a scoping review on the relationship between Digital Health Equity and Telemedicine and e-health via Scopus and Pubmed electronic databases. The following inclusion criteria were established: papers on the relationship between digital health equity and telemedicine and e-health, written in English and with no time limits. All study designs were eligible, including those that have utilized qualitative and quantitative methods, methodology, or guidelines reports, except for meta-reviews.</p><p><strong>Results: </strong>With the advancement of technology and social media, a change in behavior in the population and the doctor-patient relationship was observed. Through the help of digital devices, the increased prevalence of social networks, and asynchronous consultations new opportunities were created to bring doctors and patients closer. The relationship has shifted from face-to-face and paternalistic to virtual communication with shared decisions in recent decades. It was observed that the advancement of technology and the use of digital resources have reshaped the roles of doctors and patients and their relationships.</p><p><strong>Conclusion: </strong>Technology is the leading cause for an informed, more involved, and responsible patient. However, physicians have conflicting opinions about the use of these technologies. While recognizing its benefits for patients, they are also concerned about digital health and its impact.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":""},"PeriodicalIF":2.1,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of music therapy on children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. 音乐治疗对儿童和青少年注意力缺陷/多动障碍的效果:系统回顾和荟萃分析。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2025-07-18 DOI: 10.47626/2237-6089-2024-1020
Adriana de Oliveira Goes, Antonio Egidio Nardi, Laiana Azevedo Quagliato

Objective: Attention-deficit/hyperactivity disorder (ADHD) affects approximately 7% of children and 5% of adolescents worldwide. ADHD is characterized by inattention, hyperactivity and impulsivity as symptoms. The exact mechanism underlying this disorder is still unclear, but genetic and environmental factors play important roles. In recent years, research and treatment options have increased, including medication and/or therapeutic interventions such as music therapy. There is evidence showing benefits of music therapy on mental health, such as autism spectrum disorder (ASD). However, results regarding ADHD are limited. The aim of this meta-analysis was to verify whether music therapy is an effective tool for improving symptoms in children and adolescents with ADHD.

Methods: In accordance with PRISMA guidelines, we systematically searched the Virtual Health Library, SciELO, PubMed and Cochrane Library databases. This article included original research that investigated the effect of music therapy on hyperactive and impulsive symptoms in children and adolescents with ADHD.

Results: Music therapy was associated with a trend of efficacy involving ADHD symptoms (effect size: 1.18; CI: -3.8 - 0.21; p = 0.08). Additionally, a significant amount of heterogeneity among trials was found (I2 = 92 %). The lack of studies involving music therapy, ADHD and brain imaging, as well as limited investigation of inattention symptoms in studied articles are limitations of this article.

Conclusion: Music therapy is an important therapeutic tool for ADHD. Therefore, future research should include more robust samples and measurement scales, follow-up after experiments and further exploration of the potential connections among ADHD, music therapy, neuroimaging and neuroscientific fields.

背景:注意缺陷/多动障碍(ADHD)影响全世界约7%的儿童和5%的青少年。ADHD的特点是注意力不集中、多动和冲动。这种疾病的确切机制尚不清楚,但遗传和环境因素起着重要作用。近年来,研究和治疗选择有所增加,包括药物和/或治疗干预措施,如音乐疗法。有证据表明,音乐疗法对心理健康有好处,比如自闭症谱系障碍(ASD)。然而,关于ADHD的结果是有限的。目的:本荟萃分析的目的是验证音乐疗法是否是改善儿童和青少年多动症症状的有效工具。方法:按照PRISMA指南,系统检索虚拟健康图书馆、SciELO、PubMed和Cochrane图书馆数据库。这篇文章包括了调查音乐疗法对多动症儿童和青少年多动和冲动症状的影响的原始研究。结果:音乐治疗与涉及ADHD症状的疗效趋势相关(效应量:1.18;Ci: -3.8 - 0.21;P = 0.08)。此外,发现试验之间存在显著的异质性(I2 = 92%)。缺乏涉及音乐治疗、多动症和脑成像的研究,以及研究文章中对注意力不集中症状的有限调查是本文的局限性。结论:音乐治疗是ADHD的重要治疗手段。因此,未来的研究应包括更稳健的样本和测量量表,实验后的随访,以及进一步探索ADHD与音乐治疗、神经影像学和神经科学领域之间的潜在联系。
{"title":"Outcomes of music therapy on children and adolescents with attention-deficit/hyperactivity disorder: a systematic review and meta-analysis.","authors":"Adriana de Oliveira Goes, Antonio Egidio Nardi, Laiana Azevedo Quagliato","doi":"10.47626/2237-6089-2024-1020","DOIUrl":"10.47626/2237-6089-2024-1020","url":null,"abstract":"<p><strong>Objective: </strong>Attention-deficit/hyperactivity disorder (ADHD) affects approximately 7% of children and 5% of adolescents worldwide. ADHD is characterized by inattention, hyperactivity and impulsivity as symptoms. The exact mechanism underlying this disorder is still unclear, but genetic and environmental factors play important roles. In recent years, research and treatment options have increased, including medication and/or therapeutic interventions such as music therapy. There is evidence showing benefits of music therapy on mental health, such as autism spectrum disorder (ASD). However, results regarding ADHD are limited. The aim of this meta-analysis was to verify whether music therapy is an effective tool for improving symptoms in children and adolescents with ADHD.</p><p><strong>Methods: </strong>In accordance with PRISMA guidelines, we systematically searched the Virtual Health Library, SciELO, PubMed and Cochrane Library databases. This article included original research that investigated the effect of music therapy on hyperactive and impulsive symptoms in children and adolescents with ADHD.</p><p><strong>Results: </strong>Music therapy was associated with a trend of efficacy involving ADHD symptoms (effect size: 1.18; CI: -3.8 - 0.21; p = 0.08). Additionally, a significant amount of heterogeneity among trials was found (I2 = 92 %). The lack of studies involving music therapy, ADHD and brain imaging, as well as limited investigation of inattention symptoms in studied articles are limitations of this article.</p><p><strong>Conclusion: </strong>Music therapy is an important therapeutic tool for ADHD. Therefore, future research should include more robust samples and measurement scales, follow-up after experiments and further exploration of the potential connections among ADHD, music therapy, neuroimaging and neuroscientific fields.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20241020"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144664026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional impairment and post-stroke depression: a 6-month longitudinal study. 功能障碍和脑卒中后抑郁:一项为期6个月的纵向研究。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2023-04-04 DOI: 10.47626/2237-6089-2022-0589
Larissa P Borlina Beltrami, Paula Teixeira Marques, Francisco Jaime Lopes Barbosa, Viviane H Flumignan Zetola, Marcos Christiano Lange, Raffael Massuda

Objective: In recent decades, there have been considerable advances in treatment and prevention of acute ischemic stroke (IS). However, even after treatment, approximately two-thirds of patients with IS have some degree of disability that requires rehabilitation, along with an increased likelihood of developing psychiatric disorders, particularly depression. The objective of this study was to determine the predictors of post-stroke depression in a 6-month period in patients with IS.

Methods: Ninety-seven patients with IS without previous depression were included in the study. The study protocol was applied during hospitalization and at 30, 90, and 180 days after hospital discharge. A binary logistic regression was then conducted. Age, sex, marital status, occupation, educational level, thrombolysis, National Institute of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS) score, Barthel Index (BI), and Mini-Mental State Examination (MMSE) score were included as independent variables.

Results: Of the 97 patients, 24% of patients developed post-stroke depression. In the longitudinal follow-up, an mRS score of > 0 was the lone significant predictor of development of depression (odds ratio [OR] = 5.38; 95% confidence interval [95%CI] 1.25-23.12; p < 0.05).

Conclusion: Our results showed that in patients without previous depression, functional impairment of any degree is associated with a 5-fold greater chance of development of depression in the first 6 months post-stroke compared to patients without functional impairment.

目的:近几十年来,在急性缺血性脑卒中(IS)的治疗和预防方面取得了相当大的进展。然而,即使在治疗后,大约三分之二的IS患者仍有一定程度的残疾,需要康复,同时患精神疾病,特别是抑郁症的可能性也在增加。本研究的目的是确定6个月内IS患者脑卒中后抑郁的预测因素。方法:纳入97例既往无抑郁症的IS患者。研究方案适用于住院期间以及出院后30、90和180天。然后进行二元逻辑回归。以年龄、性别、婚姻状况、职业、文化程度、溶栓、美国国立卫生研究院卒中量表(NIHSS)、改良Rankin量表(mRS)评分、Barthel指数(BI)、简易精神状态检查(MMSE)评分为自变量。结果:97例患者中,24%的患者出现脑卒中后抑郁。在纵向随访中,mRS评分为b>是抑郁症发展的唯一显著预测因子(优势比[OR] = 5.38;95%置信区间[95% ci] 1.25 ~ 23.12;P < 0.05)。结论:我们的研究结果显示,在先前没有抑郁症的患者中,与没有功能障碍的患者相比,任何程度的功能障碍与中风后前6个月发生抑郁症的机会增加了5倍。
{"title":"Functional impairment and post-stroke depression: a 6-month longitudinal study.","authors":"Larissa P Borlina Beltrami, Paula Teixeira Marques, Francisco Jaime Lopes Barbosa, Viviane H Flumignan Zetola, Marcos Christiano Lange, Raffael Massuda","doi":"10.47626/2237-6089-2022-0589","DOIUrl":"10.47626/2237-6089-2022-0589","url":null,"abstract":"<p><strong>Objective: </strong>In recent decades, there have been considerable advances in treatment and prevention of acute ischemic stroke (IS). However, even after treatment, approximately two-thirds of patients with IS have some degree of disability that requires rehabilitation, along with an increased likelihood of developing psychiatric disorders, particularly depression. The objective of this study was to determine the predictors of post-stroke depression in a 6-month period in patients with IS.</p><p><strong>Methods: </strong>Ninety-seven patients with IS without previous depression were included in the study. The study protocol was applied during hospitalization and at 30, 90, and 180 days after hospital discharge. A binary logistic regression was then conducted. Age, sex, marital status, occupation, educational level, thrombolysis, National Institute of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS) score, Barthel Index (BI), and Mini-Mental State Examination (MMSE) score were included as independent variables.</p><p><strong>Results: </strong>Of the 97 patients, 24% of patients developed post-stroke depression. In the longitudinal follow-up, an mRS score of > 0 was the lone significant predictor of development of depression (odds ratio [OR] = 5.38; 95% confidence interval [95%CI] 1.25-23.12; p < 0.05).</p><p><strong>Conclusion: </strong>Our results showed that in patients without previous depression, functional impairment of any degree is associated with a 5-fold greater chance of development of depression in the first 6 months post-stroke compared to patients without functional impairment.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20220589"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9248976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying borderline traits in a Brazilian community sample using the Dimensional Clinical Personality Inventory 2 factors. 使用维度临床人格量表2因素识别巴西社区样本中的边缘特征。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-12-20 DOI: 10.47626/2237-6089-2024-0871
André Pereira Gonçalves, Lucas de Francisco Carvalho

Objective: This study aimed to examine the discriminative capacity of the Dimensional Clinical Personality Inventory 2 (IDCP-2) factors for identifying individuals with elevated borderline personality disorder (BPD) traits within a Brazilian community sample while proposing an optimal cutoff score for distinguishing high BPD trait levels.

Methods: The participant cohort consisted of 1,469 adults who completed assessments, including the Level of Personality Functioning Scale - Brief Form 2.0 (LPFS), the Personality Inventory for Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) (PID-5), the IDCP-2, and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) - Personality Questionnaire (PQ-SCID-II). We categorized participants into three groups utilizing the traits outlined in the Alternative Model of Personality Disorders (AMPD) from DSM-5 Section III. Furthermore, latent profile analysis based on PID-5 facets revealed the existence of three empirically derived profiles.

Results: Our findings demonstrate that IDCP-2 factors exhibited substantial discriminative power, marked by large effect sizes across most factors. To minimize false negatives, we suggest a conservative cutoff score of 22 as the most effective threshold for identifying individuals with high levels of BPD traits.

Conclusion: The BPD score generated from IDCP-2 factors holds significant promise in clinical practice, offering valuable insights into a patient's propensity to exhibit a BPD profile and providing a comprehensive clinical profile.

目的:本研究旨在检验维度临床人格量表2 (IDCP-2)因素在识别巴西社区样本中边缘型人格障碍(BPD)特征升高个体方面的判别能力,同时提出区分高BPD特征水平的最佳临界值。方法:1469名成年人完成了人格功能水平量表-简要表格2.0 (LPFS)、DSM-5人格量表(PID-5)、IDCP-2和DSM-IV人格问卷(PQ-SCID-II)的结构化临床访谈。我们利用DSM-5第三节中人格障碍替代模型(AMPD)中概述的特征将参与者分为三组。此外,基于PID-5方面的潜在剖面分析显示存在三个经验推导的剖面。结果:我们的研究结果表明,IDCP-2因素表现出实质性的判别能力,在大多数因素中表现出较大的效应量。为了最大限度地减少假阴性,我们建议保守的临界值为22分,作为识别高水平BPD特征个体的最有效阈值。结论:由IDCP-2因子生成的BPD评分在临床实践中具有重要的前景,为了解患者表现出BPD特征的倾向提供了有价值的见解,并提供了全面的临床特征。
{"title":"Identifying borderline traits in a Brazilian community sample using the Dimensional Clinical Personality Inventory 2 factors.","authors":"André Pereira Gonçalves, Lucas de Francisco Carvalho","doi":"10.47626/2237-6089-2024-0871","DOIUrl":"10.47626/2237-6089-2024-0871","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to examine the discriminative capacity of the Dimensional Clinical Personality Inventory 2 (IDCP-2) factors for identifying individuals with elevated borderline personality disorder (BPD) traits within a Brazilian community sample while proposing an optimal cutoff score for distinguishing high BPD trait levels.</p><p><strong>Methods: </strong>The participant cohort consisted of 1,469 adults who completed assessments, including the Level of Personality Functioning Scale - Brief Form 2.0 (LPFS), the Personality Inventory for Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) (PID-5), the IDCP-2, and the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) - Personality Questionnaire (PQ-SCID-II). We categorized participants into three groups utilizing the traits outlined in the Alternative Model of Personality Disorders (AMPD) from DSM-5 Section III. Furthermore, latent profile analysis based on PID-5 facets revealed the existence of three empirically derived profiles.</p><p><strong>Results: </strong>Our findings demonstrate that IDCP-2 factors exhibited substantial discriminative power, marked by large effect sizes across most factors. To minimize false negatives, we suggest a conservative cutoff score of 22 as the most effective threshold for identifying individuals with high levels of BPD traits.</p><p><strong>Conclusion: </strong>The BPD score generated from IDCP-2 factors holds significant promise in clinical practice, offering valuable insights into a patient's propensity to exhibit a BPD profile and providing a comprehensive clinical profile.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20240871"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the use of lithium for suicidality in acute settings: rationale, risks, and uncertainties. 探索在急性期使用锂治疗自杀:理由、风险和不确定性。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-03-22 DOI: 10.47626/2237-6089-2024-0811
Rafael Ramos Amaral, Pedro V S Magalhães

Lithium's well-documented efficacy in preventing suicide over the long term prompts consideration of its potential for more rapid antisuicidal effects. However, evidence supporting such acute efficacy is limited. Weighing against its possible rapid benefits are significant concerns regarding lithium's side-effect profile - particularly toxicity, renal impairment, and weight gain - and the often necessary delay in achieving therapeutic levels. Moreover, the multifaceted nature of suicidality complicates identifying short-term outcomes and disentangling lithium's effects on suicidal thoughts from broader reductions in depressive symptoms. While lithium may remain invaluable for some high-risk patients in emergency settings, its routine use as a rapid-acting agent for acute suicidality is currently not well supported.

长期来看,锂在预防自杀方面的功效得到了充分证明,这促使人们考虑它可能具有更快速的抗自杀作用。然而,支持这种急性疗效的证据有限。考虑到它可能迅速带来的好处,人们对锂的副作用——尤其是毒性、肾损害和体重增加——以及达到治疗水平的必要延迟感到担忧。此外,自杀的多面性使确定短期结果和将锂对自杀念头的影响从抑郁症状的广泛减少中分离出来变得复杂。虽然锂在紧急情况下对一些高风险患者可能仍然是无价的,但它作为急性自杀的速效药物的常规使用目前还没有得到很好的支持。
{"title":"Exploring the use of lithium for suicidality in acute settings: rationale, risks, and uncertainties.","authors":"Rafael Ramos Amaral, Pedro V S Magalhães","doi":"10.47626/2237-6089-2024-0811","DOIUrl":"10.47626/2237-6089-2024-0811","url":null,"abstract":"<p><p>Lithium's well-documented efficacy in preventing suicide over the long term prompts consideration of its potential for more rapid antisuicidal effects. However, evidence supporting such acute efficacy is limited. Weighing against its possible rapid benefits are significant concerns regarding lithium's side-effect profile - particularly toxicity, renal impairment, and weight gain - and the often necessary delay in achieving therapeutic levels. Moreover, the multifaceted nature of suicidality complicates identifying short-term outcomes and disentangling lithium's effects on suicidal thoughts from broader reductions in depressive symptoms. While lithium may remain invaluable for some high-risk patients in emergency settings, its routine use as a rapid-acting agent for acute suicidality is currently not well supported.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20240811"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12677799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140871845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication. 利益相关者的利益对迷幻药研究安全结果报告的影响及对科学传播的启示。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-08-01 DOI: 10.47626/2237-6089-2024-0866
Elena Koning, Marco Solmi, Elisa Brietzke

Psychedelics are a group of psychoactive substances that produce complex and subjective changes to consciousness and carry unique safety considerations. There is a growing body of work investigating the use of psychedelics in mental health treatment alongside increasing socio-cultural and political acceptance. This rapid evolution has prompted corporations to fund psychedelic clinical trials, leading to a potential rise in conflicts of interest in relevant studies and publications. However, the body of evidence for the safety and efficacy of psychedelic-assisted psychotherapy is early. There is concern regarding the introduction of bias in psychedelic clinical trials and the selective reporting of results amidst and beyond corporate involvement. At a crucial time in psychedelic drug reform, this paper explores the safety concerns associated with psychedelics, the potential influences of financial stakeholders on safety outcome reporting and the importance of balanced science communication in maintaining public health and safety.

迷幻药是一类精神活性物质,能产生复杂的主观意识变化,并具有独特的安全考虑。随着社会文化和政治上对迷幻药的接受程度不断提高,研究迷幻药用于心理健康治疗的研究成果也越来越多。这种快速发展促使企业资助迷幻药临床试验,导致相关研究和出版物中的利益冲突可能增加。然而,有关迷幻药辅助精神疗法治疗精神疾病的安全性和有效性的证据还为时尚早。在迷幻药临床试验中引入偏见,以及在企业参与中和企业参与之外选择性地报告结果,这些都令人担忧。在迷幻药改革的关键时刻,本文探讨了与迷幻药相关的安全问题、金融利益相关者对安全结果报告的潜在影响以及平衡科学交流对维护公众健康和安全的重要性。
{"title":"The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication.","authors":"Elena Koning, Marco Solmi, Elisa Brietzke","doi":"10.47626/2237-6089-2024-0866","DOIUrl":"10.47626/2237-6089-2024-0866","url":null,"abstract":"<p><p>Psychedelics are a group of psychoactive substances that produce complex and subjective changes to consciousness and carry unique safety considerations. There is a growing body of work investigating the use of psychedelics in mental health treatment alongside increasing socio-cultural and political acceptance. This rapid evolution has prompted corporations to fund psychedelic clinical trials, leading to a potential rise in conflicts of interest in relevant studies and publications. However, the body of evidence for the safety and efficacy of psychedelic-assisted psychotherapy is early. There is concern regarding the introduction of bias in psychedelic clinical trials and the selective reporting of results amidst and beyond corporate involvement. At a crucial time in psychedelic drug reform, this paper explores the safety concerns associated with psychedelics, the potential influences of financial stakeholders on safety outcome reporting and the importance of balanced science communication in maintaining public health and safety.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20240866"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904264/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with suicide risk in young women with premenstrual dysphoric disorder: a population-based study. 与经前期焦虑症年轻女性自杀风险相关的因素:一项基于人口的研究。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-02-05 DOI: 10.47626/2237-6089-2023-0718
Francine Zanette Machado, Manuela Silva Silveira da Mota, Ester Pereira Dos Santos, Divya Prasad, Taiane de Azevedo Cardoso, Benicio N Frey, Karen Jansen, Luciano Dias de Mattos Souza, Thaise Campos Mondin, Flavio Kapczinski, Fernanda Pedrotti Moreira, Ricardo Azevedo da Silva

Objective: Women with premenstrual dysphoric disorder (PMDD) are more likely to report suicide ideation and behavior when compared to women without PMDD. However, there is a lack of studies investigating the risk factors for suicide risk in women with PMDD. Thus, the aim of this study is to assess the factors associated with suicide risk in young women with PMDD.

Methods: This is a cross-sectional study including 128 young women with PMDD who were recruited from the community. PMDD and suicide risk were assessed by trained psychologists using the Mini International Neuropsychiatric Interview (MINI-PLUS). Suicide risk evaluation includes six questions that assess suicidal intention, planning, and previous attempts. Subjects who answer yes to any of the six questions are classified as having current suicide risk.

Results: The prevalence of current suicide risk in women with PMDD was 28.1%. The factors associated with suicide risk in this population were: presenting current panic disorder (odds ratio [OR]: 18.71 [95% confidence interval {95%CI} 1.02-343.27], p = 0.048), a non-white skin color (OR: 4.18 [95%CI 1.28-13.61], p = 0.018), greater severity of depressive symptoms (OR: 1.22 [95%CI 1.12-1.32], p < 0.001), and history of childhood trauma (OR: 1.04 [95%CI 1.01-1.08], p = 0.010).

Conclusion: Our findings indicate that there are key sociodemographic and clinical factors associated with suicide risk in young women with PMDD, enabling clinicians to identify at-risk individuals who could benefit from further screening and interventions.

目的:与未患经前期紧张综合症(PMDD)的女性相比,患有经前期紧张综合症(PMDD)的女性更有可能报告有自杀意念和行为。然而,目前还缺乏对 PMDD 女性自杀风险因素的研究。因此,本研究旨在评估与患有PMDD的年轻女性自杀风险相关的因素:这是一项横断面研究,从社区招募了128名患有PMDD的年轻女性。由训练有素的心理学家使用迷你国际神经精神访谈(MINI-PLUS)对PMDD和自杀风险进行评估。自杀风险评估包括六个问题,分别评估自杀意向、计划和以前的自杀企图。对六个问题中任何一个问题的回答为 "是 "的受试者被归类为当前有自杀风险:结果:患有 PMDD 的女性当前自杀风险发生率为 28.1%。在这一人群中,与自杀风险相关的因素有:目前存在恐慌症(OR:18.71 [95% CI:1.02 - 343.27],P=0.048)、非白色肤色(OR:4.18 [CI 95%:1.28-13.61],P=0.018)、抑郁症状更严重(OR:1.22 [95% CI:1.12-1.32],<0.001)和童年创伤史(OR:1.04 [95% CI:1.01-1.08],0.010):我们的研究结果表明,有一些关键的社会人口学和临床因素与患有PMDD的年轻女性的自杀风险有关,从而使临床医生能够识别高危人群,使其从进一步的筛查和干预中获益。
{"title":"Factors associated with suicide risk in young women with premenstrual dysphoric disorder: a population-based study.","authors":"Francine Zanette Machado, Manuela Silva Silveira da Mota, Ester Pereira Dos Santos, Divya Prasad, Taiane de Azevedo Cardoso, Benicio N Frey, Karen Jansen, Luciano Dias de Mattos Souza, Thaise Campos Mondin, Flavio Kapczinski, Fernanda Pedrotti Moreira, Ricardo Azevedo da Silva","doi":"10.47626/2237-6089-2023-0718","DOIUrl":"10.47626/2237-6089-2023-0718","url":null,"abstract":"<p><strong>Objective: </strong>Women with premenstrual dysphoric disorder (PMDD) are more likely to report suicide ideation and behavior when compared to women without PMDD. However, there is a lack of studies investigating the risk factors for suicide risk in women with PMDD. Thus, the aim of this study is to assess the factors associated with suicide risk in young women with PMDD.</p><p><strong>Methods: </strong>This is a cross-sectional study including 128 young women with PMDD who were recruited from the community. PMDD and suicide risk were assessed by trained psychologists using the Mini International Neuropsychiatric Interview (MINI-PLUS). Suicide risk evaluation includes six questions that assess suicidal intention, planning, and previous attempts. Subjects who answer yes to any of the six questions are classified as having current suicide risk.</p><p><strong>Results: </strong>The prevalence of current suicide risk in women with PMDD was 28.1%. The factors associated with suicide risk in this population were: presenting current panic disorder (odds ratio [OR]: 18.71 [95% confidence interval {95%CI} 1.02-343.27], p = 0.048), a non-white skin color (OR: 4.18 [95%CI 1.28-13.61], p = 0.018), greater severity of depressive symptoms (OR: 1.22 [95%CI 1.12-1.32], p < 0.001), and history of childhood trauma (OR: 1.04 [95%CI 1.01-1.08], p = 0.010).</p><p><strong>Conclusion: </strong>Our findings indicate that there are key sociodemographic and clinical factors associated with suicide risk in young women with PMDD, enabling clinicians to identify at-risk individuals who could benefit from further screening and interventions.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20230718"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectives on the ketogenic diet as a non-pharmacological intervention for major depressive disorder. 生酮饮食作为重度抑郁症非药物干预措施的前景。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2025-03-21 DOI: 10.47626/2237-6089-2024-0932
Jade Shelp, Cristiano Chaves, Alexander Terpstra, Elena Koning, Fabiano A Gomes, Jennifer Fabe, Vitor Breda, Nicole Laurent, Christopher Palmer, Elisa Brietzke

Objective: Major depressive disorder (MDD) is a prevalent mood disorder characterized by persistent low mood and anhedonia, significantly impacting cognitive function and daily living. Despite available pharmacological treatments, nearly one-third of individuals with MDD do not achieve adequate symptom relief with conventional treatments. The ketogenic diet (KD), a high-fat, low-carbohydrate diet that induces ketosis, has emerged as a potential non-pharmacological intervention for MDD. The objective of this study was to provide a comprehensive perspective on the current knowledge and gaps regarding the potential antidepressant effect of the KD, emphasizing its safety, efficacy, and mechanistic pathways.

Methods: This narrative review synthesizes data from preclinical and clinical studies on the effects of KD on mood, cognitive function, and its potential as an antidepressant. Mechanistic insights from animal and human studies are explored to elucidate possible pathways through which KD may exert its effects on MDD.

Results: Evidence from animal models suggests that KD may reduce depressive-like behaviors and improve cognitive function. Preliminary human studies, including case reports and observational studies, indicate potential benefits such as mood stabilization, increased energy, and reduced depression severity. Proposed mechanisms include immune-inflammatory regulation, correction of mitochondrial dysfunction, and neurotransmitter modulation. However, key gaps remain, particularly regarding the therapeutic window, long-term efficacy, and specific mechanisms of action in MDD.

Conclusions: KD represents a promising avenue for further investigation as a non-pharmacological treatment of MDD. Further research is needed to establish its clinical utility, identify predictors of response, and assess its feasibility as a treatment option for MDD.

背景:重度抑郁障碍(MDD)是一种普遍存在的情绪障碍,其特征是持续的情绪低落和失神,严重影响认知功能和日常生活。尽管有药物治疗方法,但近三分之一的重度抑郁症患者在接受常规治疗后症状并没有得到充分缓解。生酮饮食(KD)是一种诱导酮病的高脂肪、低碳水化合物饮食,已成为治疗 MDD 的潜在非药物干预方法:目的:从一个全面的视角,介绍有关 KD 潜在抗抑郁作用的现有知识和差距,强调其安全性、有效性和机理途径:这篇叙述性综述综合了临床前研究和临床研究中有关 KD 对情绪、认知功能的影响及其作为抗抑郁药的潜力的数据。研究还探讨了动物和人体研究的机制,以阐明KD对MDD产生影响的可能途径:结果:来自动物模型的证据表明,KD 可减少抑郁样行为并改善认知功能。初步的人体研究(包括病例报告和观察性研究)表明,KD 有潜在的益处,如稳定情绪、增加能量和减轻抑郁的严重程度。提出的机制包括免疫炎症调节、线粒体功能障碍矫正和神经递质调节。然而,关键的差距依然存在,尤其是在治疗窗口期、长期疗效以及对 MDD 的具体作用机制方面:结论:作为一种非药物治疗 MDD 的方法,KD 是一个值得进一步研究的前景广阔的途径。需要开展进一步研究,以确定其临床效用,识别反应预测因素,并评估其作为 MDD 治疗选择的可行性。
{"title":"Perspectives on the ketogenic diet as a non-pharmacological intervention for major depressive disorder.","authors":"Jade Shelp, Cristiano Chaves, Alexander Terpstra, Elena Koning, Fabiano A Gomes, Jennifer Fabe, Vitor Breda, Nicole Laurent, Christopher Palmer, Elisa Brietzke","doi":"10.47626/2237-6089-2024-0932","DOIUrl":"10.47626/2237-6089-2024-0932","url":null,"abstract":"<p><strong>Objective: </strong>Major depressive disorder (MDD) is a prevalent mood disorder characterized by persistent low mood and anhedonia, significantly impacting cognitive function and daily living. Despite available pharmacological treatments, nearly one-third of individuals with MDD do not achieve adequate symptom relief with conventional treatments. The ketogenic diet (KD), a high-fat, low-carbohydrate diet that induces ketosis, has emerged as a potential non-pharmacological intervention for MDD. The objective of this study was to provide a comprehensive perspective on the current knowledge and gaps regarding the potential antidepressant effect of the KD, emphasizing its safety, efficacy, and mechanistic pathways.</p><p><strong>Methods: </strong>This narrative review synthesizes data from preclinical and clinical studies on the effects of KD on mood, cognitive function, and its potential as an antidepressant. Mechanistic insights from animal and human studies are explored to elucidate possible pathways through which KD may exert its effects on MDD.</p><p><strong>Results: </strong>Evidence from animal models suggests that KD may reduce depressive-like behaviors and improve cognitive function. Preliminary human studies, including case reports and observational studies, indicate potential benefits such as mood stabilization, increased energy, and reduced depression severity. Proposed mechanisms include immune-inflammatory regulation, correction of mitochondrial dysfunction, and neurotransmitter modulation. However, key gaps remain, particularly regarding the therapeutic window, long-term efficacy, and specific mechanisms of action in MDD.</p><p><strong>Conclusions: </strong>KD represents a promising avenue for further investigation as a non-pharmacological treatment of MDD. Further research is needed to establish its clinical utility, identify predictors of response, and assess its feasibility as a treatment option for MDD.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20240932"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143674740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mobile dating app use and sexual risk behavior among Brazilian undergraduate students. 巴西大学生使用手机约会应用程序和性风险行为。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-01-09 DOI: 10.47626/2237-6089-2023-0746
Edson Zangiacomi Martinez, Vitoria de Souza Pinto Frazatto, Jonathan Leonardo Gonçalves Prudencio, Guilherme Galdino, Miriane Lucindo Zucoloto

Objective: One of the most popular ways to meet new people in the modern world is through dating apps. However, their use may facilitate casual sexual encounters and quick partner changes, both of which are associated with endangering sexual health in different populations. The objective of this study is to describe the use of mobile dating apps among undergraduate students at a major Brazilian public university and investigate its associations with sexual risk behaviors and sociodemographic factors.

Methods: This is a cross-sectional study based on a web survey. The link for participation was made available to students enrolled in undergraduate courses at the eight units of Universidade de São Paulo, Campus Ribeirão Preto. Use of dating apps, sociodemographic/behavioral profile, and sexual risk behaviors were among the variables studied. The distribution of app users was calculated for each variable of interest, and prevalence ratios (PRs) were used for comparisons. PRs were reported with 95% confidence intervals (95%CI).

Results: A total of 487 students participated, with 32.9% reporting using dating apps. Male participants were more likely to use apps. Use of dating apps was associated with having multiple sexual partners and risky behaviors such as smoking, alcohol consumption, and substance abuse.

Conclusion: It is critical to describe the pattern of app use by undergraduate students and understand its influence on sexual health in order to avoid stigmatizing users. Additionally, this information can be helpful to guide the creation of strategies for using these apps as resources to promote health, such as through sharing information regarding sexual health.

介绍:交友软件是现代人结识新朋友的最流行方式之一。然而,它的使用可能会助长随意的性接触和快速更换性伴侣,而这两者在不同人群中都会危及性健康:描述巴西一所重点公立大学的本科生使用手机约会应用程序的情况,并调查其与性风险行为和社会人口因素的关联:这是一项基于网络调查的横断面研究。圣保罗大学里贝朗普雷图校区八个本科专业的学生均可通过链接参与调查。约会应用程序的使用、社会人口/行为特征和性风险行为是研究的变量之一。我们计算了每个相关变量的应用程序用户分布情况,并使用流行率(PRs)进行比较。流行率报告了 95% 的置信区间:共有 487 名学生参与调查,其中 32.9% 表示使用过约会应用程序。男性参与者更有可能使用。使用约会应用程序与拥有多个性伴侣以及吸烟、饮酒和滥用药物等危险行为有关:描述本科生使用应用程序的模式并了解其对性健康的影响至关重要,这样才能避免对用户进行污名化。此外,这些信息还有助于指导制定策略,将这些应用程序作为促进健康的资源,如有关性健康的信息共享。
{"title":"Mobile dating app use and sexual risk behavior among Brazilian undergraduate students.","authors":"Edson Zangiacomi Martinez, Vitoria de Souza Pinto Frazatto, Jonathan Leonardo Gonçalves Prudencio, Guilherme Galdino, Miriane Lucindo Zucoloto","doi":"10.47626/2237-6089-2023-0746","DOIUrl":"10.47626/2237-6089-2023-0746","url":null,"abstract":"<p><strong>Objective: </strong>One of the most popular ways to meet new people in the modern world is through dating apps. However, their use may facilitate casual sexual encounters and quick partner changes, both of which are associated with endangering sexual health in different populations. The objective of this study is to describe the use of mobile dating apps among undergraduate students at a major Brazilian public university and investigate its associations with sexual risk behaviors and sociodemographic factors.</p><p><strong>Methods: </strong>This is a cross-sectional study based on a web survey. The link for participation was made available to students enrolled in undergraduate courses at the eight units of Universidade de São Paulo, Campus Ribeirão Preto. Use of dating apps, sociodemographic/behavioral profile, and sexual risk behaviors were among the variables studied. The distribution of app users was calculated for each variable of interest, and prevalence ratios (PRs) were used for comparisons. PRs were reported with 95% confidence intervals (95%CI).</p><p><strong>Results: </strong>A total of 487 students participated, with 32.9% reporting using dating apps. Male participants were more likely to use apps. Use of dating apps was associated with having multiple sexual partners and risky behaviors such as smoking, alcohol consumption, and substance abuse.</p><p><strong>Conclusion: </strong>It is critical to describe the pattern of app use by undergraduate students and understand its influence on sexual health in order to avoid stigmatizing users. Additionally, this information can be helpful to guide the creation of strategies for using these apps as resources to promote health, such as through sharing information regarding sexual health.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20230746"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139404754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroscience-based nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs. 基于神经科学的命名法(NbN):精神药物新分类的葡萄牙语版本。
IF 2.2 Q3 PSYCHIATRY Pub Date : 2025-01-01 Epub Date: 2024-01-18 DOI: 10.47626/2237-6089-2023-0771
José Carlos Fernandes Galduróz, Aleksander Roberto Zampronio, Maria Aparecida Barbato Frazão Vital, Paulo Clemente Sallet, Joseph Zohar, Roberto Andreatini

Neuroscience-based nomenclature (NbN) is a proposal to provide a nomenclature based on neuroscience and pharmacology instead of the old disease-based classification. The NbN is based on the mechanism of action and pharmacological target and aims to assist in rational prescription, to reduce stigma, and to increase treatment adherence. Currently, the NbN is endorsed by many psychiatric associations, has been adopted by several relevant journals, and is included in major psychiatry textbooks. Therefore, it is important that the NbN is known to psychiatrists.

基于神经科学的命名法(NbN)是一项建议,旨在提供一种基于神经科学和药理学的命名法,以取代旧有的基于疾病的分类法。NbN 以作用机制和药理靶点为基础,旨在帮助合理处方、减少耻辱感并提高治疗依从性。目前,NbN 已得到许多精神病学协会的认可,被一些相关期刊采用,并被纳入主要的精神病学教科书。因此,让精神科医生了解 NbN 非常重要。
{"title":"Neuroscience-based nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs.","authors":"José Carlos Fernandes Galduróz, Aleksander Roberto Zampronio, Maria Aparecida Barbato Frazão Vital, Paulo Clemente Sallet, Joseph Zohar, Roberto Andreatini","doi":"10.47626/2237-6089-2023-0771","DOIUrl":"10.47626/2237-6089-2023-0771","url":null,"abstract":"<p><p>Neuroscience-based nomenclature (NbN) is a proposal to provide a nomenclature based on neuroscience and pharmacology instead of the old disease-based classification. The NbN is based on the mechanism of action and pharmacological target and aims to assist in rational prescription, to reduce stigma, and to increase treatment adherence. Currently, the NbN is endorsed by many psychiatric associations, has been adopted by several relevant journals, and is included in major psychiatry textbooks. Therefore, it is important that the NbN is known to psychiatrists.</p>","PeriodicalId":46305,"journal":{"name":"Trends in Psychiatry and Psychotherapy","volume":" ","pages":"e20230771"},"PeriodicalIF":2.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12904262/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139492525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Trends in Psychiatry and Psychotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1